Latest Patents News

4DS Memory Limited has successfully manufactured its first 20nm memory cell array, marking a pivotal step in its ReRAM technology development, while raising $8.6 million through a placement and Share Purchase Plan to fuel ongoing innovation.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.

Ionic Rare Earths reports major strides in sustainable magnet recycling and heavy rare earth projects, backed by strategic partnerships and a sharp reduction in losses.

Codeifai Limited reports a robust 141% increase in Q1 2025 cash receipts, driven by its revamped Digital First Engagement First strategy and the expanding ConnectQR SaaS platform. Despite rising costs, the company maintains strong margins and is strategically reviewing its Material Science division.

Novonix Limited advances its synthetic graphite production with Riverside commissioning and a new Chattanooga plant site, while winning a preliminary US trade case against Chinese imports and appointing Michael O’Kronley as CEO.

Sparc Technologies has progressed to Stage 2 of its Sparc Hydrogen joint venture with pilot plant commissioning slated for mid-2025, while also securing its first patent for photocatalytic water splitting technology in Morocco. Concurrently, its graphene-based additive ecosparc® demonstrates promising field trial results, underpinning commercial momentum.

Imugene Limited reports encouraging Phase 1b results for azer-cel in lymphoma, secures FDA Fast Track status, and strengthens patent portfolio while raising A$20 million to fuel ongoing immuno-oncology programs.

First Graphene Limited reported a successful A$2.4 million capital raise alongside promising progress in its PureGRAPH-CEM product trials in the UK and South Africa, while securing key patents and expanding distribution across Asia and South America.

Firebird Metals has made significant strides in its LMFP battery strategy, finalizing multiple offtake agreements with Chinese manufacturers and securing a mining lease for its Oakover project, positioning itself as a low-cost producer in the growing battery materials market.

EcoGraf Limited has advanced its vertically integrated battery anode materials business with a US$105 million loan mandate for the Epanko Graphite Mine, expanded mining licences, and progress in purification technology and community initiatives.

Zelira Therapeutics has enhanced its financial flexibility through a $1.15 million R&D tax refund and a $1 million At-the-Market equity facility, while progressing FDA trial preparations for its HOPE® 1 autism treatment.